Publications Database

McDougle C. J. , Kresch L. E. , Posey D. J. (2000)

Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.

Journal of Autism and Developmental Disorders

30(5), pp. 427-435

Read Abstract (New Window)

McPheeters M. L. et al. (2011)

A systematic review of medical treatments for children with autism spectrum disorders.

Pediatrics

127(5), e1312-e1321

Read Abstract (New Window) Read Full (New Window)

Memari A. et al. (2012)

Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: Perspective from a developing country.

Research in Developmental Disabilities

33(2), pp. 563-569.

Read Abstract (New Window)

Mohiuddin S. , Ghaziuddin M. (2013)

Psychopharmacology of autism spectrum disorders: A selective review.

Autism

17(6), pp. 645-654.

Read Abstract (New Window)

Moore M. L. , Eichner S. F. , Jones J. R. (2004)

Treating functional impairment of autism with selective serotonin-reuptake inhibitors.

Annals of Pharmacotherapy

38(9), pp. 1515-1519

Read Abstract (New Window)

Murray M. et al. (2014)

Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.

Psychopharmacology (Berl)

231(6), pp. 1011-1021.

Read Abstract (New Window)

Myers S. M. (2010)

Citalopram not effective for repetitive behaviour in autistic spectrum disorders.

Evidence Based Mental Health

13(1), pp. 22

Read Extract (New Window)

Myers S. M. (2007)

The status of pharmacotherapy for autism spectrum disorders.

Expert Opinion on Pharmacotherapy

8(11), pp. 1579-1603

Read Abstract (New Window)

Nadeau J. M. et al. (2011)

Treatment of comorbid anxiety and autism spectrum disorders.

Neuropsychiatry

December, 1(6), pp. 567-578.

Read Full (New Window)

Namerow L. et al. (2003)

Use of citalopram in pervasive developmental disorders.

Journal of Developmental and Behavioral Pediatrics

24(2), pp. 104-108

Read Abstract (New Window)

Niederhofer H. , Staffen W. , Mair A. (2003)

Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.

Human Psychopharmacology

18(5), pp. 389-393

Read Abstract (New Window)

Oswald D. P. , Sonenklar N. A. (2007)

Medication use among children with autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

17(3), pp. 348-355

Read Abstract (New Window)

Owley T. et al. (2010)

A pharmacogenetic study of escitalopram in autism spectrum disorders.

Autism Research

3(1), pp. 1-7.

Read Abstract (New Window)

Owley T. et al. (2005)

An open-label trial of escitalopram in pervasive developmental disorders.

Journal of the American Academy of Child and Adolescent Psychiatry

44(4), pp. 343-348

Read Abstract (New Window)

Ozbayrak K. (1997)

Sertraline in PDD.

Journal of the American Academy of Child and Adolescent Psychiatry

36(1), pp. 7-8

Read Abstract (New Window)

Palermo M. , Curatolo P. (2004)

Pharmacologic treatment of autism.

Journal of Child Neurology

19(3), pp. 155-164

Read Abstract (New Window)

Peñagarikan O. (2014)

New therapeutic options for autism spectrum disorder: Experimental evidences.

Experimental Neurobiology

December, 24(4), pp. 301-311.

Read Abstract (New Window) Read Full (New Window)

American Society of Health-System Pharmacists (2009)

Citalopram.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2009)

Clomipramine.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2008)

Desipramine

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)